Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
Background: Carriership with methicillin resistant <i>Staphylococcus aureus</i> (MRSA) is a risk for the development of secondary infections in critically ill patients. Previous studies suggest that enteral vancomycin is able to eliminate enteral carriership with MRSA. Data on individual effects of...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2022-02-01
|
| coleção: | Antibiotics |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2079-6382/11/2/263 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|